Delivery Order SPE2DB22D2006-SPE2DB24FW1GT
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $3,165.06 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 7, 2024, with an ultimate completion date of August 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm to the Defense Logistics Agency (DLA). The $2,846.20 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 4, 2024 and was not designated with a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The $1,249.24 delivery order was placed by the Defense Logistics Agency (DLA), a Defense agency, and is a firm fixed-price contract. The contract has an ultimate completion date of December 5, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of 4,565,243,375 units of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The firm-fixed-price delivery order contract has a ceiling value of $2,704.53 and a period of performance through July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $1,719.82 to supply the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,403.21 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products, with a completion date of February 28, 2024.
Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,833.05 firm fixed price delivery order contract to supply Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,443.39 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.
The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...